BCAX in the 13F filings
Bicara Therapeutics Inc · CUSIP 055477103
- Quarter end
- 31 Dec 2025
- the date the book describes
- Filed
- 19 Feb 2026
- latest of these filings; the earliest 12 Feb 2026
- Managers listing it
- 15
- at least, of 95 tracked, among listed positions
- Comparable managers
- 92
- filed both Q3 2025 and Q4 2025; 0 listed it in both
- Shares listed
- 9,585,593
- combined, among listed positions
- Reported value
- $161m
- combined, at the quarter end
Among the 92 comparable managers: 11 buyers (opened or added shares) and 8 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +2,895,899.
Managers listing BCAX in Q4 2025
15 of 15 holders
Largest increases and reductions, by shares
Increases
- Janus Henderson Group Ltdnew position · 2,646,285 shares now+2,646,285
- Citadel Advisors LLCnew position · 772,258 shares now+772,258
- Fidelity (FMR LLC)existing position · 3,347,223 shares now+648,862
- Hudson Bay Capital Management LPnew position · 150,000 shares now+150,000
- D. E. Shaw & Co.new position · 136,522 shares now+136,522
Reductions
- Millennium Management LLCexisting position · 434,699 shares now-580,193
- T. Rowe Price Associates Incexisting position · 1,559,535 shares now-195,876
- Woodline Partners LPexisting position · 232,690 shares now-116,000
- AllianceBernstein LPexisting position · 29,110 shares now-11,660
New positions and exits
New (7)
Exited (4)
- Schonfeld Strategic Advisors LLCwas $8.0m
- Marshall Wace LLPwas $1.8m
- ExodusPoint Capital Management LPwas $851k
- Point72 Asset Management LPwas $476k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q3 2024 | 4 | $38m | 4 | 0 |
| Q4 2024 | 1 | $4.8m | 0 | 3 |
| Q2 2025 | 1 | $3.7m | 1 | 0 |
| Q3 2025 | 1 | $8.0m | 1 | 1 |
| Q4 2025 | 1 | $44m | 11 | 8 |
| Q1 2026 | 1 | $66m | 10 | 8 |
| Q2 2026 | 2 | $104m | 7 | 8 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
BCAX and LLY →BCAX and TMO →BCAX and JNJ →Choose a stock to compare with BCAX →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own BCAX, latest filings →Back to the 13F Explorer →